Making USP <797> as Easy as 123: Overcoming Sterile Compounding Insourcing Challenges and Adult Versus Pediatric Considerations

The United States Pharmacopeia General Chapter 797 (USP <797>) defines the minimum standards for sterile compounding that are critical for patient safety. This educational activity will address ongoing challenges where pharmacists, pharmacy technicians, and medication safety officers report questions including strategies to bring back or increase sterile compounding in healthcare facilities and associated considerations including resources, risk assessment, and financial analysis. Additionally, this activity will discuss special considerations for adult versus pediatric compounded sterile products (CSPs) including compatibility and stability considerations, and appropriate opportunities to use standardized concentrations. This activity will use case-based questions to compare scenarios with adult patients and pediatric populations to demonstrate the differences and nuances in these patient populations with CSPs.


Tuesday, Apr. 14
1 – 2:30 p.m. ET


Webinar Registration
Registration is required for this webinar.

Speakers

Patricia Kienle

Patricia C. Kienle, MPA, BCSCP, FASHP, Activity Chair
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

Patricia C. Kienle is Director of Accreditation and Medication Safety for Cardinal Health. She received her pharmacy degree from Philadelphia College of Pharmacy and Science and a Master in Public Administration degree from Marywood University in Scranton, Pennsylvania. She is author of The Chapter <795> Answer Book, The Chapter <797> Answer Book, and The Chapter <800> Answer Book and co-author of Meeting Accreditation Standards: A Pharmacy Preparation Guide. With over 750 invited presentations and 100 publications, she has special interests in medication safety, compounding sterile preparations, accreditation, and regulatory issues.



Cindy Brasher

Cindy A. Brasher, PharmD, MS, BCSCP
Manager of Compounding
St. Jude Children's Research Center
Memphis, Tennessee

Cindy Brasher is the manager of compounding at St. Jude Children's Research Hospital. She received her PharmD from the University of Tennessee College of Pharmacy, completed the health systems pharmacy administration PGY1/PGY2 residency program at Mission Hospital in Asheville, North Carolina, and a master’s in pharmacy administration through the University of North Carolina Chapel Hill. Currently, Cindy is serving on the ASHP Section Advisory Group on Compounding and the Tennessee Pharmacist Association Compounding Society.



Jaclyn Jaskowiak

Jaclyn M. Jaskowiak, PharmD, BCPS, BCSCP
Inpatient Pharmacist Specialist, Compounding Compliance and Operations
UC San Diego Health
La Jolla, California

Jaclyn M. Jaskowiak is an Inpatient Pharmacist Specialist for compounding compliance and operations at UC San Diego Health and Affiliate Faculty at the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. She has received formal training in environmental monitoring, completed two USP designated person training programs, and completed the Comprehensive cGMP Pharmaceutical Aseptic Training Course at the University of Tennessee. Dr. Jaskowiak has over 17 years of health-system experience including inpatient, outpatient infusion center, and clinical research pharmacy services. Dr. Jaskowiak currently serves as Chair of the ASHP Section of Inpatient Care Practitioners Section Advisory Group on Compounding Practice, Chair of the CSHP Compounding Task Force, Chair of the SDSHP Compounding Committee, and is board certified in compounded sterile preparations and pharmacotherapy.


Target Audience

This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems, including all settings responsible for preparing, labeling, packaging, storing and distributing compounded sterile preparations.


Learning Objectives

  • Assess resources, financial implications, and risk for bringing back or increasing sterile compounding within healthcare facilities. 
  • Analyze the important differences in adult versus pediatric compounded sterile products including compatibility and stability considerations.

Agenda

  • 1 p.m. – Welcome and Introductions
    Patricia C. Kienle
  • 1:05 p.m. – Home is Where the Hood Is: Bringing Back or Increasing Sterile Compounding in Healthcare Institutions
    Jaclyn M. Jaskowiak
  • 1:40 p.m. – Not One Size Fits All: Special Considerations for Adult Versus Pediatric Sterile Compounding
    Cynthia A. Brasher
  • 2:20 p.m. – Faculty Discussion, Questions and Answers
    All Faculty

Accredited for CPE

ACPE #: 0204-0000-26-402-L07-P, 0204-0000-26-402-L07-T
CE Credit: 1.5 contact hours (0.15 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

 

 

ACPE logo black and white The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
ASHP Advantage logo Provided by ASHP.
Supported by an educational grant from Pfizer Inc.
For questions and assistance to participate, contact us.